Mieczysław Wośko, president and founder of Polfarmex, a leading Polish company, discusses the key factors behind the enterprise’s successful growth and the movement towards R&D to create their own treatments. Furthermore, he highlights the company’s international strategy and strong manufacturing capabilities, both for their own treatments and in the context of CMO activities, as well as the impressive social footprint of Polfarmex within the local community.
As the president and founder, could you introduce Polfarmex to our international audience?
"We are now looking to expand our impact into more markets, namely the Netherlands, Latvia, Lithuania, Germany, the UK and France."
